Nicholas A. Smith

Array ( [id] => 7466075 [patent_doc_number] => 20040101904 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-27 [patent_title] => 'Delivery of pharmaceutical agents via the human insulin receptor' [patent_app_type] => new [patent_app_number] => 10/307276 [patent_app_country] => US [patent_app_date] => 2002-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10325 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 220 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0101/20040101904.pdf [firstpage_image] =>[orig_patent_app_number] => 10307276 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6796958 [patent_doc_number] => 20030175832 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-18 [patent_title] => 'Methods for monitoring and treating amyotrophic lateral sclerosis' [patent_app_type] => new [patent_app_number] => 10/299946 [patent_app_country] => US [patent_app_date] => 2002-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 16123 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20030175832.pdf [firstpage_image] =>[orig_patent_app_number] => 10299946 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6658562 [patent_doc_number] => 20030078391 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-24 [patent_title] => 'Connective tissue growth factor-2' [patent_app_type] => new [patent_app_number] => 10/294796 [patent_app_country] => US [patent_app_date] => 2002-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10797 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0078/20030078391.pdf [firstpage_image] =>[orig_patent_app_number] => 10294796 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6990482 [patent_doc_number] => 20050089519 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-28 [patent_title] => 'Bispecific anti-cd19x anti-cd16 antibodies and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/495508 [patent_app_country] => US [patent_app_date] => 2002-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 8783 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0089/20050089519.pdf [firstpage_image] =>[orig_patent_app_number] => 10495508 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6741020 [patent_doc_number] => 20030158389 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-21 [patent_title] => 'Polypeptide variants' [patent_app_type] => new [patent_app_number] => 10/292869 [patent_app_country] => US [patent_app_date] => 2002-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 24502 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20030158389.pdf [firstpage_image] =>[orig_patent_app_number] => 10292869 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7104962 [patent_doc_number] => 20050107285 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-19 [patent_title] => 'Treatment of inflammatory conditions' [patent_app_type] => utility [patent_app_number] => 10/495377 [patent_app_country] => US [patent_app_date] => 2002-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 10366 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0107/20050107285.pdf [firstpage_image] =>[orig_patent_app_number] => 10495377 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6796880 [patent_doc_number] => 20030175754 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-18 [patent_title] => 'RVP-1 variant differentially expressed in crohns disease' [patent_app_type] => new [patent_app_number] => 10/290027 [patent_app_country] => US [patent_app_date] => 2002-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 23638 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20030175754.pdf [firstpage_image] =>[orig_patent_app_number] => 10290027 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6658309 [patent_doc_number] => 20030133934 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-17 [patent_title] => 'Method for enhancing the presentation of exogenous antigen by human antigen-presenting cells and opsonized micro particle complexes for applying this method' [patent_app_type] => new [patent_app_number] => 10/181689 [patent_app_country] => US [patent_app_date] => 2002-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6375 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0133/20030133934.pdf [firstpage_image] =>[orig_patent_app_number] => 10181689 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6739739 [patent_doc_number] => 20030157108 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-21 [patent_title] => 'Glycoprotein compositions' [patent_app_type] => new [patent_app_number] => 10/277370 [patent_app_country] => US [patent_app_date] => 2002-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 41766 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0157/20030157108.pdf [firstpage_image] =>[orig_patent_app_number] => 10277370 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6852034 [patent_doc_number] => 20030144237 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-31 [patent_title] => 'Use of inhibition of a gas6 function or of a gas6 receptor for preventing and treating a cardiovascular disease' [patent_app_type] => new [patent_app_number] => 10/257173 [patent_app_country] => US [patent_app_date] => 2002-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6988 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20030144237.pdf [firstpage_image] =>[orig_patent_app_number] => 10257173 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7369240 [patent_doc_number] => 20040092712 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-13 [patent_title] => 'Tlr/cd14 binding inhibitor' [patent_app_type] => new [patent_app_number] => 10/240403 [patent_app_country] => US [patent_app_date] => 2002-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 36817 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20040092712.pdf [firstpage_image] =>[orig_patent_app_number] => 10240403 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6654181 [patent_doc_number] => 20030077284 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-24 [patent_title] => 'Product and method for treatment of conditions associated with receptor-desensitization' [patent_app_type] => new [patent_app_number] => 10/218670 [patent_app_country] => US [patent_app_date] => 2002-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 21696 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20030077284.pdf [firstpage_image] =>[orig_patent_app_number] => 10218670 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7033117 [patent_doc_number] => 20050031626 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-10 [patent_title] => 'Binding agents with differential activity' [patent_app_type] => utility [patent_app_number] => 10/484638 [patent_app_country] => US [patent_app_date] => 2002-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 14030 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20050031626.pdf [firstpage_image] =>[orig_patent_app_number] => 10484638 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6912240 [patent_doc_number] => 20050175998 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-11 [patent_title] => 'Medicinal compositions containing fc receptor gamma-chain activator' [patent_app_type] => utility [patent_app_number] => 10/485614 [patent_app_country] => US [patent_app_date] => 2002-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 17773 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10485614 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 840540 [patent_doc_number] => 07390870 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-06-24 [patent_title] => 'Immune-enhancing peptides' [patent_app_type] => utility [patent_app_number] => 10/186035 [patent_app_country] => US [patent_app_date] => 2002-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 10670 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/390/07390870.pdf [firstpage_image] =>[orig_patent_app_number] => 10186035 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7103410 [patent_doc_number] => 20050106136 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-19 [patent_title] => '7s immunoglobulin for treatment of choroidal neovascularisation' [patent_app_type] => utility [patent_app_number] => 10/505033 [patent_app_country] => US [patent_app_date] => 2002-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 7143 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 42 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20050106136.pdf [firstpage_image] =>[orig_patent_app_number] => 10505033 [rel_patent_id] =>[rel_patent_doc_number] =>)